 Dwarikesh Sugar Industries Ltd Q2FY26 loss at Rs. 32.62 crores
Dwarikesh Sugar Industries Ltd Q2FY26 loss at Rs. 32.62 crores Nitta Gelatin India Ltd Q2 FY2025-26 consolidated profit lower at Rs. 18.42 crores
Nitta Gelatin India Ltd Q2 FY2025-26 consolidated profit lower at Rs. 18.42 crores Wheels India Ltd consolidated Q2 FY26 net profit up at Rs. 30.99 crores
Wheels India Ltd consolidated Q2 FY26 net profit up at Rs. 30.99 crores Kalpataru Projects International Ltd posts rise in Q2FY26 consolidated PAT to Rs. 240.05 crores
Kalpataru Projects International Ltd posts rise in Q2FY26 consolidated PAT to Rs. 240.05 crores Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores
Shriram Finance Ltd Q2FY26 consolidated PAT increases to Rs. 2314.17 crores 
              The Board of Directors of Dr. Lal PathLabs Ltd on May 14, 2018 approved allotment of 8,866 equity shares under the ESOP 2010 Plan of the Company.
Shares of Dr. Lal PathLabs Ltd was last trading in BSE at Rs.807.85 as compared to the previous close of Rs. 816.35. The total number of shares traded during the day was 1817 in over 182 trades.
The stock hit an intraday high of Rs. 826.35 and intraday low of 800. The net turnover during the day was Rs. 1473033.